{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:00Z","timestamp":1792788240730,"version":"4.5.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AG058518"],"award-info":[{"award-number":["T32AG058518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1NS090934"],"award-info":[{"award-number":["RF1NS090934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032490","name":"Freedom Together Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032490","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cure Alzheimer\u2019s Fund","id":[{"id":"https:\/\/ror.org\/05ewr7t48","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Apolipoprotein E (ApoE) is highly expressed in the central nervous system (CNS) where it plays a critical role in lipid homeostasis and in the etiology of Alzheimer\u2019s disease (AD) and related diseases. ApoE associates with lipids to form discoidal and spherical lipoproteins that carry lipid and protein cargo throughout the brain. In this review, we focus on the significance of ApoE as a lipoprotein and how this impacts the function of ApoE in homeostasis and disease. In the CNS, ApoE is primarily secreted by astrocytes, though other cells, including microglia, secrete ApoE under certain conditions. ApoE lipoproteins (LpE) secreted by different cell types carry unique lipids and proteins which alter its function. The lipidation state of ApoE alters its conformation and binding to different receptors and, consequently, its ultimate impact on AD pathology. Most dramatically, nonlipidated ApoE has minimal binding to the low density lipoprotein receptor (LDLR), while lipidation of ApoE restores high affinity binding to LDLR. Furthermore, the degree of ApoE lipidation also impacts ApoE receptor binding through changes in protein conformation and stoichiometry of ApoE molecules per lipoprotein. The lipidation state of ApoE also alters its interaction with amyloid-\u03b2 and tau, the proteins involved in forming amyloid plaques and neurofibrillary tangles, the pathological hallmarks of AD. LpE also carry lipids and proteins that alter the function of ApoE. Understanding how the lipid and protein content of LpE interacts with the conformational changes that occur with lipidation and maturation are essential to mechanistically understanding the role of ApoE in homeostasis and disease pathogenesis. In this review, we highlight the current understanding of LpE biology in the CNS and delineate important areas of future research.<\/jats:p>","DOI":"10.1186\/s13024-026-00970-0","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:52:42Z","timestamp":1783407162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer\u2019s disease and related disorders"],"prefix":"10.1186","volume":"21","author":[{"given":"Michael R.","family":"Strickland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"970_CR1","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006312.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"970_CR2","first-page":"182","volume":"6","author":"M Koch","year":"2017","unstructured":"Koch M, Furtado JD, Falk K, Leypoldt F, Mukamal KJ, Jensen MK. Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2017;6:182\u20137.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"970_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arterioscler Thromb Vasc Biol. 2016;36:1305\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"970_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. Neuron. 2021;109:205\u201321.","journal-title":"Neuron"},{"key":"970_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"970_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr., Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180\u20134.","journal-title":"Nat Genet"},{"key":"970_CR7","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","volume":"25","author":"RW Mahley","year":"1984","unstructured":"Mahley RW, Innerarity TL, Rall SC, Weisgraber KH. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res. 1984;25:1277\u201394.","journal-title":"J Lipid Res"},{"key":"970_CR8","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/ATVBAHA.123.318284","volume":"44","author":"M Tsujita","year":"2024","unstructured":"Tsujita M, Melchior JT, Yokoyama S. Lipoprotein Particles in Cerebrospinal Fluid. Arterioscler Thromb Vasc Biol. 2024;44:1042\u201352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"970_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","volume":"42","author":"S Koch","year":"2001","unstructured":"Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg H-J, Buhmann C, Beisiegel U. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res. 2001;42:1143\u201351.","journal-title":"J Lipid Res"},{"key":"970_CR10","doi-asserted-by":"publisher","first-page":"eadi5571","DOI":"10.1126\/sciadv.adi5571","volume":"9","author":"NJ Merrill","year":"2023","unstructured":"Merrill NJ, Davidson WS, He Y, Diaz Ludovico I, Sarkar S, Berger MR, McDermott JE, Van Eldik LJ, Wilcock DM, Monroe ME, et al. Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health. Sci Adv. 2023;9:eadi5571.","journal-title":"Sci Adv"},{"key":"970_CR11","doi-asserted-by":"crossref","unstructured":"Strickland MR, Wang Z, Golden LR, Wang H, Lu P, Ren Y, Tabor GT, Zhao N, Ulrich JD, Han X, et al. Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differences based on cell type and ApoE isoform. J Lipid Res 2026;101000.","DOI":"10.1016\/j.jlr.2026.101000"},{"key":"970_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, Weil MT, Su M, Sen P, Ruhwedel T, Mitkovski M, Trendelenburg G, Lutjohann D, et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science. 2018;359:684\u20138.","journal-title":"Science"},{"key":"970_CR13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","volume":"31","author":"KH Weisgraber","year":"1990","unstructured":"Weisgraber KH. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J Lipid Res. 1990;31:1503\u201311.","journal-title":"J Lipid Res"},{"key":"970_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/tra.12467","volume":"18","author":"CN Takacs","year":"2017","unstructured":"Takacs CN, Andreo U, Belote RL, Pulupa J, Scull MA, Gleason CE, Rice CM, Simon SM. Green fluorescent protein-tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress. Traffic. 2017;18:192\u2013204.","journal-title":"Traffic"},{"key":"970_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","volume":"14","author":"TV Huynh","year":"2019","unstructured":"Huynh TV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, Finn MB, Spellman R, Manis M, Tanzi RE, et al. Lack of hepatic apoE does not influence early Abeta deposition: observations from a new APOE knock-in model. Mol Neurodegener. 2019;14:37.","journal-title":"Mol Neurodegener"},{"key":"970_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1172\/JCI115288","volume":"88","author":"MF Linton","year":"1991","unstructured":"Linton MF, Gish R, Hubl ST, Butler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest. 1991;88:270\u201381.","journal-title":"J Clin Invest"},{"key":"970_CR17","doi-asserted-by":"crossref","unstructured":"Strickland MR, Rau MJ, Summers B, Basore K, Wulf J 2nd, Jiang H, Chen Y, Ulrich JD, Randolph GJ, Zhang R, et al. Apolipoprotein E secreted by astrocytes forms antiparallel dimers in discoidal lipoproteins. Neuron. 2024;112:1100\u2013e11091105.","DOI":"10.1016\/j.neuron.2023.12.018"},{"key":"970_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2004.11.005","volume":"19","author":"M Morikawa","year":"2005","unstructured":"Morikawa M, Fryer JD, Sullivan PM, Christopher EA, Wahrle SE, DeMattos RB, O\u2019Dell MA, Fagan AM, Lashuel HA, Walz T, et al. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta. Neurobiol Dis. 2005;19:66\u201376.","journal-title":"Neurobiol Dis"},{"key":"970_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-0186(01)00049-3","volume":"39","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, Sullivan PM, Fagan AM, Han X, Holtzman DM. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem Int. 2001;39:415\u201325.","journal-title":"Neurochem Int"},{"key":"970_CR20","doi-asserted-by":"publisher","first-page":"30001","DOI":"10.1074\/jbc.274.42.30001","volume":"274","author":"AM Fagan","year":"1999","unstructured":"Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, Getz GS, Reardon CA, Lukens J, Shah JA, LaDu MJ. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-\/-), and human apoE transgenic mice. J Biol Chem. 1999;274:30001\u20137.","journal-title":"J Biol Chem"},{"key":"970_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1161\/ATVBAHA.108.164350","volume":"28","author":"M Kockx","year":"2008","unstructured":"Kockx M, Jessup W, Kritharides L. Regulation of endogenous apolipoprotein E secretion by macrophages. Arterioscler Thromb Vasc Biol. 2008;28:1060\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"970_CR22","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1016\/S0021-9258(18)81907-X","volume":"264","author":"ME Wernette-Hammond","year":"1989","unstructured":"Wernette-Hammond ME, Lauer SJ, Corsini A, Walker D, Taylor JM, Rall SC. Glycosylation of Human Apolipoprotein E. J Biol Chem. 1989;264:9094\u2013101.","journal-title":"J Biol Chem"},{"key":"970_CR23","doi-asserted-by":"publisher","first-page":"9788","DOI":"10.1016\/S0021-9258(18)34141-3","volume":"257","author":"SK Basu","year":"1982","unstructured":"Basu SK, Ho YK, Brown MS, Bilheimer DW, Anderson RG, Goldstein JL. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem. 1982;257:9788\u201395.","journal-title":"J Biol Chem"},{"key":"970_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/01.ATV.0000193627.12516.1d","volume":"26","author":"ZH Huang","year":"2006","unstructured":"Huang ZH, Fitzgerald ML, Mazzone T. Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression. Arterioscler Thromb Vasc Biol. 2006;26:157\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"970_CR25","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, Holtzman DM. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem. 2004;279:40987\u201393.","journal-title":"J Biol Chem"},{"key":"970_CR26","doi-asserted-by":"publisher","first-page":"41197","DOI":"10.1074\/jbc.M407962200","volume":"279","author":"V Hirsch-Reinshagen","year":"2004","unstructured":"Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL. Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain. J Biol Chem. 2004;279:41197\u2013207.","journal-title":"J Biol Chem"},{"key":"970_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1096\/fj.00-0798com","volume":"15","author":"A Von Eckardstein","year":"2001","unstructured":"Von Eckardstein A, Langer C, Engel T, Schaukal I, Cignarella A, Reinhardt J, Lorkowski S, Li Z, Zhou X, Cullen P, Assmann G. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J. 2001;15:1555\u201361.","journal-title":"FASEB J"},{"key":"970_CR28","doi-asserted-by":"publisher","first-page":"25966","DOI":"10.1074\/jbc.M401177200","volume":"279","author":"M Kockx","year":"2004","unstructured":"Kockx M, Rye KA, Gaus K, Quinn CM, Wright J, Sloane T, Sviridov D, Fu Y, Sullivan D, Burnett JR, et al. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. J Biol Chem. 2004;279:25966\u201377.","journal-title":"J Biol Chem"},{"key":"970_CR29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/01.ATV.11.4.1007","volume":"11","author":"H Robenek","year":"1991","unstructured":"Robenek H, Schmitz G. Abnormal processing of Golgi elements and lysosomes in Tangier disease. Arterioscler Thromb. 1991;11:1007\u201320.","journal-title":"Arterioscler Thromb"},{"key":"970_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0022-2275(20)38681-8","volume":"28","author":"FL Johnson","year":"1987","unstructured":"Johnson FL, Swift LL, Rudel LL. Nascent lipoproteins from recirculating and nonrecirculating liver perfusions and from the hepatic Golgi apparatus of African green monkeys. J Lipid Res. 1987;28:549\u201364.","journal-title":"J Lipid Res"},{"key":"970_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2014.04.037","volume":"1570","author":"J Ito","year":"2014","unstructured":"Ito J, Nagayasu Y, Miura Y, Yokoyama S, Michikawa M. Astrocyte\u05f3s endogenous apoE generates HDL-like lipoproteins using previously synthesized cholesterol through interaction with ABCA1. Brain Res. 2014;1570:1\u201312.","journal-title":"Brain Res"},{"key":"970_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1194\/jlr.M014365","volume":"52","author":"J Fan","year":"2011","unstructured":"Fan J, Stukas S, Wong C, Chan J, May S, DeValle N, Hirsch-Reinshagen V, Wilkinson A, Oda MN, Wellington CL. An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia. J Lipid Res. 2011;52:1605\u201316.","journal-title":"J Lipid Res"},{"key":"970_CR33","doi-asserted-by":"publisher","first-page":"42333","DOI":"10.1074\/jbc.M107461200","volume":"276","author":"J Heeren","year":"2001","unstructured":"Heeren J, Grewal T, Jackle S, Beisiegel U. Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo. J Biol Chem. 2001;276:42333\u20138.","journal-title":"J Biol Chem"},{"key":"970_CR34","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1194\/jlr.M500503-JLR200","volume":"47","author":"NA Braun","year":"2006","unstructured":"Braun NA, Mohler PJ, Weisgraber KH, Hasty AH, Linton MF, Yancey PG, Su YR, Fazio S, Swift LL. Intracellular trafficking of recycling apolipoprotein E in Chinese hamster ovary cells. J Lipid Res. 2006;47:1176\u201386.","journal-title":"J Lipid Res"},{"key":"970_CR35","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1194\/jlr.M400104-JLR200","volume":"45","author":"MH Farkas","year":"2004","unstructured":"Farkas MH, Weisgraber KH, Shepherd VL, Linton MF, Fazio S, Swift LL. The recycling of apolipoprotein E and its amino-terminal 22\u00a0kDa fragment. J Lipid Res. 2004;45:1546\u201354.","journal-title":"J Lipid Res"},{"key":"970_CR36","doi-asserted-by":"publisher","first-page":"14370","DOI":"10.1074\/jbc.M209006200","volume":"278","author":"J Heeren","year":"2003","unstructured":"Heeren J, Grewal T, Laatsch A, Rottke D, Rinninger F, Enrich C, Beisiegel U. Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization. J Biol Chem. 2003;278:14370\u20138.","journal-title":"J Biol Chem"},{"key":"970_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0022-2275(20)37435-6","volume":"38","author":"J Deng","year":"1997","unstructured":"Deng J, Rudick V, Rudick M, Dory L. Investigation of plasma membrane-associated apolipoprotein E in primary macrophages. J Lipid Res. 1997;38:217\u201327.","journal-title":"J Lipid Res"},{"key":"970_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0022-2275(20)33337-X","volume":"40","author":"M Schmitt","year":"1999","unstructured":"Schmitt M, Grand-Perret T. Regulated turnover of a cell surface-associated pool of newly synthesized apolipoprotein E in HepG2 cells. J Lipid Res. 1999;40:39\u201349.","journal-title":"J Lipid Res"},{"key":"970_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/biof.1187","volume":"40","author":"S Wang","year":"2014","unstructured":"Wang S, Smith JD. ABCA1 and nascent HDL biogenesis. BioFactors. 2014;40:547\u201354.","journal-title":"BioFactors"},{"key":"970_CR40","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280:43224\u201335.","journal-title":"J Biol Chem"},{"key":"970_CR41","doi-asserted-by":"publisher","first-page":"43243","DOI":"10.1074\/jbc.M508781200","volume":"280","author":"V Hirsch-Reinshagen","year":"2005","unstructured":"Hirsch-Reinshagen V, Maia LF, Burgess BL, Blain JF, Naus KE, McIsaac SA, Parkinson PF, Chan JY, Tansley GH, Hayden MR, et al. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J Biol Chem. 2005;280:43243\u201356.","journal-title":"J Biol Chem"},{"key":"970_CR42","doi-asserted-by":"publisher","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Hartman RE, Bales KR, Paul SM, Holtzman DM. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem. 2005;280:43236\u201342.","journal-title":"J Biol Chem"},{"key":"970_CR43","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR, et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. 2008;118:671\u201382.","journal-title":"J Clin Invest"},{"key":"970_CR44","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, Finn MB, Hoyle R, Keyser J, Lefton KB, et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest. 2018;128:2144\u201355.","journal-title":"J Clin Invest"},{"key":"970_CR45","doi-asserted-by":"crossref","unstructured":"Kaji S, Berghoff SA, Spieth L, Schlaphoff L, Sasmita AO, Vitale S, B\u00fcschgens L, Kedia S, Zirngibl M, Nazarenko T, et al. Apolipoprotein E aggregation in microglia initiates Alzheimer\u2019s disease pathology by seeding \u03b2-amyloidosis. Immunity. 2024.","DOI":"10.1016\/j.immuni.2024.11.024"},{"key":"970_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1471-4159.2004.02183.x","volume":"88","author":"Y Liang","year":"2004","unstructured":"Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li SD, Jiang XC, et al. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem. 2004;88:623\u201334.","journal-title":"J Neurochem"},{"key":"970_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","volume":"112","author":"A Litvinchuk","year":"2024","unstructured":"Litvinchuk A, Suh JH, Guo JL, Lin K, Davis SS, Bien-Ly N, Tycksen E, Tabor GT, Remolina Serrano J, Manis M, et al. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron. 2024;112:384\u2013e403388.","journal-title":"Neuron"},{"key":"970_CR48","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1523\/JNEUROSCI.1051-10.2010","volume":"30","author":"NF Fitz","year":"2010","unstructured":"Fitz NF, Cronican A, Pham T, Fogg A, Fauq AH, Chapman R, Lefterov I, Koldamova R. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J Neurosci. 2010;30:6862\u201372.","journal-title":"J Neurosci"},{"key":"970_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/neu.2010.1595","volume":"28","author":"DJ Loane","year":"2011","unstructured":"Loane DJ, Washington PM, Vardanian L, Pocivavsek A, Hoe HS, Duff KE, Cernak I, Rebeck GW, Faden AI, Burns MP. Modulation of ABCA1 by an LXR agonist reduces beta-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma. 2011;28:225\u201336.","journal-title":"J Neurotrauma"},{"key":"970_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","volume":"181","author":"MB Fessler","year":"2018","unstructured":"Fessler MB. The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease. Pharmacol Ther. 2018;181:1\u201312.","journal-title":"Pharmacol Ther"},{"key":"970_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21775\/cimb.022.041","volume":"22","author":"Z Ma","year":"2017","unstructured":"Ma Z, Deng C, Hu W, Zhou J, Fan C, Di S, Liu D, Yang Y, Wang D. Liver X Receptors and their Agonists: Targeting for Cholesterol Homeostasis and Cardiovascular Diseases. Curr Issues Mol Biol. 2017;22:41\u201364.","journal-title":"Curr Issues Mol Biol"},{"key":"970_CR52","doi-asserted-by":"crossref","unstructured":"Weisgraber KH. Apolipoprotein E: structure-function relationships. In: Anfinsen CB, Edsall JT, Richards FM, Eisenberg DS: Academic Press; editors. Adv Protein Chem. 1994;45:249\u2013302.","DOI":"10.1016\/S0065-3233(08)60642-7"},{"key":"970_CR53","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1126\/science.2063194","volume":"252","author":"C Wilson","year":"1991","unstructured":"Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science. 1991;252:1817\u201322.","journal-title":"Science"},{"key":"970_CR54","doi-asserted-by":"publisher","first-page":"20775","DOI":"10.1074\/jbc.M003508200","volume":"275","author":"B Lu","year":"2000","unstructured":"Lu B, Morrow JA, Weisgraber KH. Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid. J Biol Chem. 2000;275:20775\u201381.","journal-title":"J Biol Chem"},{"key":"970_CR55","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ab.2007.09.005","volume":"372","author":"T Yamamoto","year":"2008","unstructured":"Yamamoto T, Choi HW, Ryan RO. Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor. Anal Biochem. 2008;372:222\u20136.","journal-title":"Anal Biochem"},{"key":"970_CR56","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/S0021-9258(18)53895-3","volume":"268","author":"A Jonas","year":"1993","unstructured":"Jonas A, Steinmetz A, Churgay L. The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. J Biol Chem. 1993;268:1596\u2013602.","journal-title":"J Biol Chem"},{"key":"970_CR57","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1074\/jbc.M510851200","volume":"281","author":"CA Peters-Libeu","year":"2006","unstructured":"Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH. Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem. 2006;281:1073\u20139.","journal-title":"J Biol Chem"},{"key":"970_CR58","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1107\/S1744309105032410","volume":"61","author":"Y Newhouse","year":"2005","unstructured":"Newhouse Y, Peters-Libeu C, Weisgraber KH. Crystallization and preliminary X-ray diffraction analysis of apolipoprotein E-containing lipoprotein particles. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005;61:981\u20134.","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"970_CR59","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.123.065959","volume":"149","author":"Y He","year":"2024","unstructured":"He Y, Pavanello C, Hutchins PM, Tang C, Pourmousa M, Vaisar T, Song HD, Pastor RW, Remaley AT, Goldberg IJ, et al. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs. Circulation. 2024;149:774\u201387.","journal-title":"Circulation"},{"key":"970_CR60","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1074\/mcp.RA118.000878","volume":"18","author":"Y He","year":"2019","unstructured":"He Y, Song HD, Anantharamaiah GM, Palgunachari MN, Bornfeldt KE, Segrest JP, Heinecke JW. Apolipoprotein A1 Forms 5\/5 and 5\/4 Antiparallel Dimers in Human High-density Lipoprotein. Mol Cell Proteom. 2019;18:854\u201364.","journal-title":"Mol Cell Proteom"},{"key":"970_CR61","doi-asserted-by":"publisher","first-page":"e1006165","DOI":"10.1371\/journal.pcbi.1006165","volume":"14","author":"N Henry","year":"2018","unstructured":"Henry N, Krammer EM, Stengel F, Adams Q, Van Liefferinge F, Hubin E, Chaves R, Efremov R, Aebersold R, Vandenbussche G, et al. Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach. PLoS Comput Biol. 2018;14:e1006165.","journal-title":"PLoS Comput Biol"},{"key":"970_CR62","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1046\/j.1471-4159.1998.70031235.x","volume":"70","author":"JR Guyton","year":"1998","unstructured":"Guyton JR, Miller SE, Martin ME, Khan WA, Roses AD, Strittmatter WJ. Novel large apolipoprotein E-containing lipoproteins of density 1.006\u20131.060\u00a0g\/ml in human cerebrospinal fluid. J Neurochem. 1998;70:1235\u201340.","journal-title":"J Neurochem"},{"key":"970_CR63","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1046\/j.1471-4159.1998.70052070.x","volume":"70","author":"MJ LaDu","year":"1998","unstructured":"LaDu MJ, Gilligan SM, Lukens JR, Cabana VG, Reardon CA, Van Eldik LJ, Holtzman DM. Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem. 1998;70:2070\u201381.","journal-title":"J Neurochem"},{"key":"970_CR64","doi-asserted-by":"publisher","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","volume":"262","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem. 1987;262:14352\u201360.","journal-title":"J Biol Chem"},{"key":"970_CR65","doi-asserted-by":"publisher","first-page":"e18841","DOI":"10.1371\/journal.pone.0018841","volume":"6","author":"V Kumar","year":"2011","unstructured":"Kumar V, Butcher SJ, Oorni K, Engelhardt P, Heikkonen J, Kaski K, Ala-Korpela M, Kovanen PT. Three-dimensional cryoEM reconstruction of native LDL particles to 16A resolution at physiological body temperature. PLoS ONE. 2011;6:e18841.","journal-title":"PLoS ONE"},{"key":"970_CR66","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","volume":"46","author":"J Ruiz","year":"2005","unstructured":"Ruiz J, Kouiavskaia D, Migliorini M, Robinson S, Saenko EL, Gorlatova N, Li D, Lawrence D, Hyman BT, Weisgraber KH, Strickland DK. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res. 2005;46:1721\u201331.","journal-title":"J Lipid Res"},{"key":"970_CR67","doi-asserted-by":"publisher","first-page":"25531","DOI":"10.1074\/jbc.272.41.25531","volume":"272","author":"T Simmons","year":"1997","unstructured":"Simmons T, Newhouse YM, Arnold KS, Innerarity TL, Weisgraber KH. Human low density lipoprotein receptor fragment. Successful refolding of a functionally active ligand-binding domain produced in Escherichia coli. J Biol Chem. 1997;272:25531\u20136.","journal-title":"J Biol Chem"},{"key":"970_CR68","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1073\/pnas.70.7.2015","volume":"70","author":"RJ Havel","year":"1973","unstructured":"Havel RJ, Kane JP. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A. 1973;70:2015\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"970_CR69","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/269604a0","volume":"269","author":"G Utermann","year":"1977","unstructured":"Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977;269:604\u20137.","journal-title":"Nature"},{"key":"970_CR70","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1016\/S0021-9258(19)70808-4","volume":"255","author":"RE Pitas","year":"1980","unstructured":"Pitas RE, Innerarity TL, Mahley RW. Cell surface receptor binding of phospholipid. protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J Biol Chem. 1980;255:5454\u201360.","journal-title":"J Biol Chem"},{"key":"970_CR71","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1194\/jlr.M800584-JLR200","volume":"50","author":"V Hirsch-Reinshagen","year":"2009","unstructured":"Hirsch-Reinshagen V, Donkin J, Stukas S, Chan J, Wilkinson A, Fan J, Parks JS, Kuivenhoven JA, Lutjohann D, Pritchard H, Wellington CL. LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins. J Lipid Res. 2009;50:885\u201393.","journal-title":"J Lipid Res"},{"key":"970_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0005-2760(89)90019-2","volume":"1006","author":"EL Gong","year":"1989","unstructured":"Gong EL, Nichols AV, Weisgraber KH, Forte TM, Shore VG, Blanche PJ. Discoidal complexes containing apolipoprotein E and their transformation by lecithin-cholesterol acyltransferase. Biochim Biophys Acta. 1989;1006:317\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"970_CR73","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1074\/jbc.270.1.189","volume":"270","author":"KA Rye","year":"1995","unstructured":"Rye KA, Hime NJ, Barter PJ. The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins. J Biol Chem. 1995;270:189\u201396.","journal-title":"J Biol Chem"},{"key":"970_CR74","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M049940","volume":"55","author":"S Stukas","year":"2014","unstructured":"Stukas S, Freeman L, Lee M, Wilkinson A, Ossoli A, Vaisman B, Demosky S, Chan J, Hirsch-Reinshagen V, Remaley AT, Wellington CL. LCAT deficiency does not impair amyloid metabolism in APP\/PS1 mice. J Lipid Res. 2014;55:1721\u20139.","journal-title":"J Lipid Res"},{"key":"970_CR75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","volume":"188","author":"JL Guo","year":"2025","unstructured":"Guo JL, Braun D, Fitzgerald GA, Hsieh YT, Rouge L, Litvinchuk A, Steffek M, Propson NE, Heffner CM, Discenza C, et al. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. Cell. 2025;188:187\u2013e206126.","journal-title":"Cell"},{"key":"970_CR76","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S0022-2275(20)32039-3","volume":"41","author":"N Demeester","year":"2000","unstructured":"Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart JC, Santens P, Mulleners E, Engelborghs S, De Deyn PP, Vandekerckhove J, et al. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer\u2019s disease. J Lipid Res. 2000;41:963\u201374.","journal-title":"J Lipid Res"},{"key":"970_CR77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13195-023-01241-6","volume":"15","author":"M Turri","year":"2023","unstructured":"Turri M, Conti E, Pavanello C, Gastoldi F, Palumbo M, Bernini F, Aprea V, Re F, Barbiroli A, Emide D, et al. Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer\u2019s disease. Alzheimers Res Ther. 2023;15:95.","journal-title":"Alzheimers Res Ther"},{"key":"970_CR78","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1194\/jlr.M500525-JLR200","volume":"47","author":"KA Rye","year":"2006","unstructured":"Rye KA, Bright R, Psaltis M, Barter PJ. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E. J Lipid Res. 2006;47:1025\u201336.","journal-title":"J Lipid Res"},{"key":"970_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2008.07.047","volume":"1232","author":"H Qureischie","year":"2008","unstructured":"Qureischie H, Heun R, Lutjohann D, Popp J, Jessen F, Ledschbor-Frahnert C, Thiele H, Maier W, Hentschel F, Kelemen P, Kolsch H. CETP polymorphisms influence cholesterol metabolism but not Alzheimer\u2019s disease risk. Brain Res. 2008;1232:1\u20136.","journal-title":"Brain Res"},{"key":"970_CR80","doi-asserted-by":"publisher","first-page":"e15131513","DOI":"10.1016\/j.neurobiolaging.2013.12.032","volume":"35","author":"Q Li","year":"2014","unstructured":"Li Q, Huang P, He QC, Lin QZ, Wu J, Yin RX. Association between the CETP polymorphisms and the risk of Alzheimer\u2019s disease, carotid atherosclerosis, longevity, and the efficacy of statin therapy. Neurobiol Aging. 2014;35:e15131513\u20131523.","journal-title":"Neurobiol Aging"},{"key":"970_CR81","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00415-005-0945-2","volume":"253","author":"E Rodriguez","year":"2006","unstructured":"Rodriguez E, Mateo I, Infante J, Llorca J, Berciano J, Combarros O. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer\u2019s disease risk associated with APOE epsilon4 allele. J Neurol. 2006;253:181\u20135.","journal-title":"J Neurol"},{"key":"970_CR82","doi-asserted-by":"publisher","first-page":"100394","DOI":"10.1016\/j.tjpad.2025.100394","volume":"13","author":"MH Davidson","year":"2026","unstructured":"Davidson MH, Szarek M, Scheltens P, Vijverberg E, Hsieh A, Ditmarsch M, Kling D, Curcio D, Nicholls SJ, Ray KK, et al. Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease. J Prev Alzheimers Dis. 2026;13:100394.","journal-title":"J Prev Alzheimers Dis"},{"key":"970_CR83","first-page":"369","volume":"32","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Tozuka M, Yamauchi K, Sugano M, Nakabayashi T, Okumura N, Hidaka H, Katsuyama T, Higuchi K. Predominant Apolipoprotein J Exists as Lipid-poor Mixtures in Cerebrospinal Fluid. Annals Clin Lab Sci. 2002;32:369\u201376.","journal-title":"Annals Clin Lab Sci"},{"key":"970_CR84","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbalip.2011.11.005","volume":"1821","author":"MJ LaDu","year":"2012","unstructured":"LaDu MJ, Munson GW, Jungbauer L, Getz GS, Reardon CA, Tai LM, Yu C. Preferential interactions between ApoE-containing lipoproteins and Abeta revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift. Biochim Biophys Acta. 2012;1821:295\u2013302.","journal-title":"Biochim Biophys Acta"},{"key":"970_CR85","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions. Proc Natl Acad Sci U S A. 2013;110:E1807\u20131816.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"970_CR86","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","volume":"64","author":"J Kim","year":"2009","unstructured":"Kim J, Castellano JM, Jiang H, Basak JM, Parsadanian M, Pham V, Mason SM, Paul SM, Holtzman DM. Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance. Neuron. 2009;64:632\u201344.","journal-title":"Neuron"},{"key":"970_CR87","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"CC Liu","year":"2017","unstructured":"Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, Kanekiyo T, Holtzman DM, Bu G. Astrocytic LRP1 Mediates Brain Abeta Clearance and Impacts Amyloid Deposition. J Neurosci. 2017;37:4023\u201331.","journal-title":"J Neurosci"},{"key":"970_CR88","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm ML, Liu CC, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA, Murray ME, Sullivan PM, et al. APOE4-mediated amyloid-beta pathology depends on its neuronal receptor LRP1. J Clin Invest. 2019;129:1272\u20137.","journal-title":"J Clin Invest"},{"key":"970_CR89","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1172\/JCI127578","volume":"129","author":"MR Strickland","year":"2019","unstructured":"Strickland MR, Holtzman DM. Dr. Jekyll and Mr. Hyde: ApoE explains opposing effects of neuronal LRP1. J Clin Invest. 2019;129:969\u201371.","journal-title":"J Clin Invest"},{"key":"970_CR90","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi Y, Andhey PS, Ising C, Wang K, Snipes LL, Boyer K, Lawson S, Yamada K, Qin W, Manis M, et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron. 2021;109:2413\u2013e24262417.","journal-title":"Neuron"},{"key":"970_CR91","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, Wang C, Park J, Tabor GT, Jiang H, et al. APOE3ch alters microglial response and suppresses Abeta-induced tau seeding and spread. Cell. 2024;187:428\u2013e445420.","journal-title":"Cell"},{"key":"970_CR92","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"970_CR93","doi-asserted-by":"publisher","first-page":"30121","DOI":"10.1074\/jbc.271.47.30121","volume":"271","author":"AM Fagan","year":"1996","unstructured":"Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem. 1996;271:30121\u20135.","journal-title":"J Biol Chem"},{"key":"970_CR94","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019Loughlin E, Xu Y, Fanek Z, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47:566\u2013e581569.","journal-title":"Immunity"},{"key":"970_CR95","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169:1276\u2013e12901217.","journal-title":"Cell"},{"key":"970_CR96","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Abeta accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener. 2022;17:13.","journal-title":"Mol Neurodegener"},{"key":"970_CR97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/glia.24105","volume":"70","author":"CM Henningfield","year":"2022","unstructured":"Henningfield CM, Arreola MA, Soni N, Spangenberg EE, Green KN. Microglia-specific ApoE knock-out does not alter Alzheimer\u2019s disease plaque pathogenesis or gene expression. Glia. 2022;70:287\u2013302.","journal-title":"Glia"},{"key":"970_CR98","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41590-023-01627-6","volume":"24","author":"Z Yin","year":"2023","unstructured":"Yin Z, Rosenzweig N, Kleemann KL, Zhang X, Brandao W, Margeta MA, Schroeder C, Sivanathan KN, Silveira S, Gauthier C, et al. APOE4 impairs the microglial response in Alzheimer\u2019s disease by inducing TGFbeta-mediated checkpoints. Nat Immunol. 2023;24:1839\u201353.","journal-title":"Nat Immunol"},{"key":"970_CR99","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM, Zhou Y, Reinartz M, Choi S, Jiang H, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047\u201358.","journal-title":"J Exp Med"},{"key":"970_CR100","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997;17:263\u20134.","journal-title":"Nat Genet"},{"key":"970_CR101","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/jnr.20458","volume":"80","author":"S Vuletic","year":"2005","unstructured":"Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ. Reduced CSF PLTP activity in Alzheimer\u2019s disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro. J Neurosci Res. 2005;80:406\u201313.","journal-title":"J Neurosci Res"},{"key":"970_CR102","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3233\/JAD-2008-15307","volume":"15","author":"S Vuletic","year":"2008","unstructured":"Vuletic S, Li G, Peskind ER, Kennedy H, Marcovina SM, Leverenz JB, Petrie EC, Lee VM, Galasko D, Schellenberg GD, Albers JJ. Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. J Alzheimers Dis. 2008;15:409\u201317.","journal-title":"J Alzheimers Dis"},{"key":"970_CR103","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1094\u20139.","journal-title":"Nat Genet"},{"key":"970_CR104","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"970_CR105","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019;25:496\u2013506.","journal-title":"Nat Med"},{"key":"970_CR106","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657\u2013e16741657.","journal-title":"Neuron"},{"key":"970_CR107","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","volume":"25","author":"J Blumenfeld","year":"2024","unstructured":"Blumenfeld J, Yip O, Kim MJ, Huang Y. Cell type-specific roles of APOE4 in Alzheimer disease. Nat Rev Neurosci. 2024;25:91\u2013110.","journal-title":"Nat Rev Neurosci"},{"key":"970_CR108","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M, He L, Mae MA, Andrae J, Ando K, Del Gaudio F, Nahar K, Lebouvier T, Lavina B, Gouveia L, et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554:475\u201380.","journal-title":"Nature"},{"key":"970_CR109","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","volume":"603","author":"AC Yang","year":"2022","unstructured":"Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, et al. A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk. Nature. 2022;603:885\u201392.","journal-title":"Nature"},{"key":"970_CR110","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris N, Blumenfeld J, Agrawal A, Traglia M, Grone B, Zilberter M, Yip O, Rao A, Nelson MR, Hao Y, et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat Aging. 2023;3:275\u201396.","journal-title":"Nat Aging"},{"key":"970_CR111","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, Effenberger A, Chen CY, Maner-Smith K, Hajjar I, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611:769\u201379.","journal-title":"Nature"},{"key":"970_CR112","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/ATVBAHA.119.313169","volume":"40","author":"Y Yamazaki","year":"2020","unstructured":"Yamazaki Y, Shinohara M, Yamazaki A, Ren Y, Asmann YW, Kanekiyo T, Bu G. ApoE (Apolipoprotein E) in Brain Pericytes Regulates Endothelial Function in an Isoform-Dependent Manner by Modulating Basement Membrane Components. Arterioscler Thromb Vasc Biol. 2020;40:128\u201344.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"970_CR113","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41591-020-0886-4","volume":"26","author":"JW Blanchard","year":"2020","unstructured":"Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, Victor MB, Bonner JM, Mathys H, Lin YT, et al. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26:952\u201363.","journal-title":"Nat Med"},{"key":"970_CR114","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1083\/jcb.107.3.1207","volume":"107","author":"RA Majack","year":"1988","unstructured":"Majack RA, Castle CK, Goodman LV, Weisgraber KH, Mahley RW, Shooter EM, Gebicke-Haerter PJ. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol. 1988;107:1207\u201313.","journal-title":"J Cell Biol"},{"key":"970_CR115","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1042\/bj20031352","volume":"378","author":"CM Quinn","year":"2004","unstructured":"Quinn CM, Kagedal K, Terman A, Stroikin U, Brunk UT, Jessup W, Garner B. Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis. Biochem J. 2004;378:753\u201361.","journal-title":"Biochem J"},{"key":"970_CR116","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41593-024-01757-6","volume":"27","author":"A Anfray","year":"2024","unstructured":"Anfray A, Schaeffer S, Hattori Y, Santisteban MM, Casey N, Wang G, Strickland M, Zhou P, Holtzman DM, Anrather J, et al. A cell-autonomous role for border-associated macrophages in ApoE4 neurovascular dysfunction and susceptibility to white matter injury. Nat Neurosci. 2024;27:2138\u201351.","journal-title":"Nat Neurosci"},{"key":"970_CR117","doi-asserted-by":"publisher","first-page":"12525","DOI":"10.1021\/bi050872j","volume":"44","author":"LA Schneeweis","year":"2005","unstructured":"Schneeweis LA, Koppaka V, Lund-Katz S, Phillips MC, Axelsen PH. Structural analysis of lipoprotein E particles. Biochemistry. 2005;44:12525\u201334.","journal-title":"Biochemistry"},{"key":"970_CR118","doi-asserted-by":"publisher","first-page":"8831","DOI":"10.1016\/S0021-9258(17)39427-9","volume":"260","author":"N Zorich","year":"1985","unstructured":"Zorich N, Jonas A, Pownall HJ. Activation of lecithin cholesterol acyltransferase by human apolipoprotein E in discoidal complexes with lipids. J Biol Chem. 1985;260:8831\u20137.","journal-title":"J Biol Chem"},{"key":"970_CR119","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1194\/jlr.M085332","volume":"59","author":"AL Cooke","year":"2018","unstructured":"Cooke AL, Morris J, Melchior JT, Street SE, Jerome WG, Huang R, Herr AB, Smith LE, Segrest JP, Remaley AT, et al. A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res. 2018;59:1244\u201355.","journal-title":"J Lipid Res"},{"key":"970_CR120","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2202-11-23","volume":"11","author":"DA Elliott","year":"2010","unstructured":"Elliott DA, Halliday GM, Garner B. Apolipoprotein-E forms dimers in human frontal cortex and hippocampus. BMC Neurosci. 2010;11:23.","journal-title":"BMC Neurosci"},{"key":"970_CR121","doi-asserted-by":"publisher","first-page":"12029","DOI":"10.1016\/S0021-9258(18)99060-5","volume":"266","author":"KH Weisgraber","year":"1991","unstructured":"Weisgraber KH, Shinto LH. Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J Biol Chem. 1991;266:12029\u201334.","journal-title":"J Biol Chem"},{"key":"970_CR122","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1172\/JCI110829","volume":"71","author":"SC Rall Jr","year":"1983","unstructured":"Rall SC Jr., Weisgraber KH, Innerarity TL, Mahley RW. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia. J Clin Invest. 1983;71:1023\u201331.","journal-title":"J Clin Invest"},{"key":"970_CR123","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ajmg.1320200226","volume":"20","author":"WA Gahl","year":"1985","unstructured":"Gahl WA, Gregg RE, Hoeg JM, Fisher E. In vivo alteration of a mutant human protein using the free thiol cysteamine. Am J Med Genet. 1985;20:409\u201317.","journal-title":"Am J Med Genet"},{"key":"970_CR124","doi-asserted-by":"publisher","first-page":"110435","DOI":"10.1016\/j.celrep.2022.110435","volume":"38","author":"K Lindner","year":"2022","unstructured":"Lindner K, Beckenbauer K, van Ek LC, Titeca K, de Leeuw SM, Awwad K, Hanke F, Korepanova AV, Rybin V, van der Kam EL, et al. Isoform- and cell-state-specific lipidation of ApoE in astrocytes. Cell Rep. 2022;38:110435.","journal-title":"Cell Rep"},{"key":"970_CR125","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1038\/s41467-021-23762-0","volume":"12","author":"NF Fitz","year":"2021","unstructured":"Fitz NF, Nam KN, Wolfe CM, Letronne F, Playso BE, Iordanova BE, Kozai TDY, Biedrzycki RJ, Kagan VE, Tyurina YY, et al. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease. Nat Commun. 2021;12:3416.","journal-title":"Nat Commun"},{"key":"970_CR126","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.atherosclerosis.2014.10.016","volume":"237","author":"Y Li","year":"2014","unstructured":"Li Y, He PP, Zhang DW, Zheng XL, Cayabyab FS, Yin WD, Tang CK. Lipoprotein lipase: from gene to atherosclerosis. Atherosclerosis. 2014;237:597\u2013608.","journal-title":"Atherosclerosis"},{"key":"970_CR127","doi-asserted-by":"publisher","first-page":"100872","DOI":"10.1016\/j.jlr.2025.100872","volume":"66","author":"KG Sprenger","year":"2025","unstructured":"Sprenger KG, Lietzke EE, Melchior JT, Bruce KD. Lipid and lipoprotein metabolism in microglia: Alzheimer\u2019s disease mechanisms and interventions. J Lipid Res. 2025;66:100872.","journal-title":"J Lipid Res"},{"key":"970_CR128","doi-asserted-by":"publisher","first-page":"106983","DOI":"10.1016\/j.nbd.2025.106983","volume":"212","author":"CM Friday","year":"2025","unstructured":"Friday CM, Stephens IO, Smith CT, Lee S, Satish D, Devanney NA, Cohen S, Morganti JM, Gordon SM, Johnson LA. APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses. Neurobiol Dis. 2025;212:106983.","journal-title":"Neurobiol Dis"},{"key":"970_CR129","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, Palovics R, Munson CN, Long C, Johansson PK, Yip O, Dong W, Rawat E, West E, Schlachetzki JCM, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. 2024;628:154\u201361.","journal-title":"Nature"},{"key":"970_CR130","doi-asserted-by":"crossref","unstructured":"Windham IA, Powers AE, Ragusa JV, Wallace ED, Zanellati MC, Williams VH, Wagner CH, White KK, Cohen S. APOE traffics to astrocyte lipid droplets and modulates triglyceride saturation and droplet size. J Cell Biol. 2024;223.","DOI":"10.1083\/jcb.202305003"},{"key":"970_CR131","doi-asserted-by":"publisher","first-page":"116841","DOI":"10.1016\/j.celrep.2025.116841","volume":"45","author":"GT Tabor","year":"2026","unstructured":"Tabor GT, Litvinchuk A, Chen Y, Allison A, Sun EW, van Lengerich B, Davis SS, West E, Schlachetzki JCM, Zeng C, et al. Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration and endolysosomal lipid accumulation in male PS19 mice. Cell Rep. 2026;45:116841.","journal-title":"Cell Rep"},{"key":"970_CR132","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1016\/S0021-9258(18)55263-7","volume":"266","author":"E Sehayek","year":"1991","unstructured":"Sehayek E, Eisenberg S. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem. 1991;266:18259\u201367.","journal-title":"J Biol Chem"},{"key":"970_CR133","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1742-2094-9-192","volume":"9","author":"E Cudaback","year":"2012","unstructured":"Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, Montine TJ, Keene CD. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. J Neuroinflammation. 2012;9:192.","journal-title":"J Neuroinflammation"},{"key":"970_CR134","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1194\/jlr.RA120000919","volume":"62","author":"Y Hu","year":"2021","unstructured":"Hu Y, Meuret C, Martinez A, Yassine HN, Nedelkov D. Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer\u2019s disease. J Lipid Res. 2021;62:100014.","journal-title":"J Lipid Res"},{"key":"970_CR135","doi-asserted-by":"crossref","unstructured":"Zhou X, Chen Y, Mok KY, Kwok TCY, Mok VCT, Guo Q, Ip FC, Chen Y, Mullapudi N, et al. Alzheimer\u2019s disease neuroimaging I,: non-coding variability at the APOE locus contributes to the Alzheimer\u2019s risk. Nat Commun. 2019;10:3310.","DOI":"10.1038\/s41467-019-10945-z"},{"key":"970_CR136","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1016\/S0021-9258(17)34612-4","volume":"253","author":"KH Weisgraber","year":"1978","unstructured":"Weisgraber KH, Mahley RW. Apoprotein (E\u2013A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem. 1978;253:6281\u20138.","journal-title":"J Biol Chem"},{"key":"970_CR137","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0005-2760(91)90034-F","volume":"1083","author":"I Borghini","year":"1991","unstructured":"Borghini I, James RW, Blatter MC, Pometta D. Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta. 1991;1083:139\u201346.","journal-title":"Biochim Biophys Acta"},{"key":"970_CR138","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/clinchem\/45.9.1431","volume":"45","author":"T Katsuyama","year":"1999","unstructured":"Katsuyama T, Kondo Y, Hidaka E, Hidaka H, Tozuka M, Yamauchi K. Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E. Clin Chem. 1999;45:1431\u20138.","journal-title":"Clin Chem"},{"key":"970_CR139","doi-asserted-by":"publisher","first-page":"e38013","DOI":"10.1371\/journal.pone.0038013","volume":"7","author":"KR Wildsmith","year":"2012","unstructured":"Wildsmith KR, Basak JM, Patterson BW, Pyatkivskyy Y, Kim J, Yarasheski KE, Wang JX, Mawuenyega KG, Jiang H, Parsadanian M, et al. In vivo human apolipoprotein E isoform fractional turnover rates in the CNS. PLoS ONE. 2012;7:e38013.","journal-title":"PLoS ONE"},{"key":"970_CR140","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12031-018-1217-9","volume":"67","author":"S Bhatia","year":"2019","unstructured":"Bhatia S, Kim WS, Shepherd CE, Halliday GM. Apolipoprotein D Upregulation in Alzheimer\u2019s Disease but Not Frontotemporal Dementia. J Mol Neurosci. 2019;67:125\u201332.","journal-title":"J Mol Neurosci"},{"key":"970_CR141","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0306-4522(03)00529-3","volume":"122","author":"F Glockner","year":"2003","unstructured":"Glockner F, Ohm TG. Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuroscience. 2003;122:103\u201310.","journal-title":"Neuroscience"},{"key":"970_CR142","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/S0022-2275(20)41336-7","volume":"33","author":"F Blanco-Vaca","year":"1992","unstructured":"Blanco-Vaca F, Via DP, Yang CY, Massey JB, Pownall HJ. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J Lipid Res. 1992;33:1785\u201396.","journal-title":"J Lipid Res"},{"key":"970_CR143","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","volume":"599","author":"KA Guttenplan","year":"2021","unstructured":"Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, Munch AE, Blum JA, Fine J, Neal MC, et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599:102\u20137.","journal-title":"Nature"},{"key":"970_CR144","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0022-2836(86)90436-5","volume":"187","author":"CC Luo","year":"1986","unstructured":"Luo CC, Li WH, Moore MN, Chan L. Structure and Evolution of the Apolipoprotein Multigene Family. J Mol Biol. 1986;187:325\u201340.","journal-title":"J Mol Biol"},{"key":"970_CR145","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/S0022-2275(20)38213-4","volume":"30","author":"CC Luo","year":"1989","unstructured":"Luo CC, Li WH, Chan L. Structure and expression of dog apolipoprotein A-I, E, and C-I mRNAs: implications for the evolution and functional constraints of apolipoprotein structure. J Lipid Res. 1989;30:1735\u201346.","journal-title":"J Lipid Res"},{"key":"970_CR146","doi-asserted-by":"crossref","unstructured":"Yassine HN, Hugo C, O\u2019Donovan B, Stephens IO, Johnson LA, Cole G, Tcw J, Johansson J, Kisler K, Chiba-Falek O. APOE-targeted therapeutics for Alzheimer\u2019s disease. J Neurosci. 2025;45.","DOI":"10.1523\/JNEUROSCI.1388-25.2025"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00970-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:02:41Z","timestamp":1791223361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00970-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":146,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["970"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00970-0","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.M.H. has equity and is on the scientific advisory board of C2N Diagnostics and is on the scientific advisory boards of Denali, Genentech, Acta, and Switch Therapeutics, and consults for Pfizer, Roche and Novartis. D.M.H. is an editor at Molecular Neurodegeneration and is also a guest editor for the special collection of reviews on the topic of \u201cLipids in Neurodegeneration.\u201d","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"62"}}